ACE2 and COVID-19: In this review, we introduce key pathophysiological concepts related to the interplay between the angiotensin-converting enzyme 2 (ACE2), desintegrin and metalloproteinase domain 17 (ADAM17) and the type II transmembrane serine protease (TMPRSS2) in the major clinical disorders reported in COVID-19 patients.